Piper Sandler reaffirmed its positive stance on Inspire Medical Systems (NYSE:NYSE:INSP), maintaining an Overweight rating with a $260.00 price target. The endorsement comes after a steep 14.15% ...
Discover the latest FDA-cleared orthopedic and spine devices and technologies, including robotics, implants, and bone graft systems.
Inspire Medical Systems (INSP) said its revenue for the fourth quarter of 2024 is anticipated to be in the range of $239.5 million to ...
Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to 81.
After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...
This means that users of older devices can now experience the latest Android features and improvements, thanks to the tireless efforts of the LineageOS community. For those unfamiliar with LineageOS, ...
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 4.1% of Inspire Medical Systems ...
Illustration by Ben Denzer; source photographs by Paul Denzer and Daria LeGrand Supported by By Marisa Meltzer For years, an at-home beauty device meant ... to bring home medical-grade self ...
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...
and Inspire Medical Systems (INSP). - Inspire has developed a neurostimulation device approved by the FDA. The company is preparing for a full commercial launch of its next-gen Inspire V therapy ...
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...